The diagnosis of breast cancer subtype was initially developed based on gene-expression signature [21]; however, the hormone receptor expression, HER2 status, and proliferation markers were clinically replaced by multi-gene assay in the analyses [15]. The gene discussed is ERBB2; the disease is breast carcinoma.